Company / Shares Outstanding
Compass Therapeutics, Inc. Shares Outstanding History
FY2018-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
137.8M
FY2024
5-year range
30.8M / 137.8M
FY2020-FY2024
Trend
+8.0%
vs FY2023
Sector context
#72 of 212
Health Care
What the data says
At 137820000.00, Compass Therapeutics, Inc.'s shares outstanding ranks #141 of 212 in the Health Care sector. Shares Outstanding has increased for 6 consecutive years, from 5000000.00 in FY2018 to 137820000.00 in FY2024.
Based on SEC 10-K filings.
137820000.00 in FY2024 with a 5-year CAGR of +83.1%.
Increased from 126302000.00 to 137820000.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +29.9%
- 5-Year CAGR
- +83.1%
- 10-Year CAGR
- -
Sector benchmark
#141 of 212 in Health CareTop 66% of 212This company 137.8M Sector average 310.0M
▼
-55.5% below sector average
Key checks
Key Insights
- Compass Therapeutics, Inc.'s shares outstanding has grown for 6 consecutive years.
- In FY2024, shares outstanding increased 8.0% year-over-year.
- Ranks #72 out of 212 companies in the Health Care sector.
- Lowest shares outstanding in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | 137.8M | +8.0% |
| FY2023 | 127.7M | +1.1% |
| FY2022 | 126.3M | +100.9% |
| FY2021 | 62.9M | +104.3% |
| FY2020 | 30.8M | +360.0% |
| FY2019 | 6.7M | +33.8% |
| FY2018 | 5.0M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026